Solid Biosciences (SLDB) Total Debt (2024 - 2026)
Quarterly results put Total Debt at $3.4 million for Q1 2026, down 30.21% from a year ago — trailing twelve months through Mar 2026 was $3.4 million (down 30.21% YoY), and the annual figure for FY2025 was $9.2 million, up 192.06%.
Solid Biosciences has reported Total Debt over the past 3 years, most recently at $3.4 million for Q1 2026.
- Total Debt reached $3.4 million in Q1 2026 per SLDB's latest filing, down from $9.2 million in the prior quarter.
- Across five years, Total Debt topped out at $9.2 million in Q4 2025 and bottomed at $3.2 million in Q4 2024.
- Median Total Debt over the past 3 years was $4.8 million (2025), compared with a mean of $5.2 million.
- The largest annual shift saw Total Debt surged 192.06% in 2025 before it plummeted 30.21% in 2026.
- Over 3 years, Total Debt stood at $3.2 million in 2024, then skyrocketed by 192.06% to $9.2 million in 2025, then crashed by 63.59% to $3.4 million in 2026.
- Business Quant data shows Total Debt for SLDB at $3.4 million in Q1 2026, $9.2 million in Q4 2025, and $6.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.99 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 3.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.35 Mn |
| Dec 31, 2025 | 9.20 Mn |
| Sep 30, 2025 | 6.55 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Mar 31, 2025 | 4.80 Mn |
| Dec 31, 2024 | 3.15 Mn |
| Sep 30, 2024 | 3.40 Mn |